<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D"><gtr:id>E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D</gtr:id><gtr:name>Kiel University</gtr:name><gtr:department>Institute of Physiology</gtr:department><gtr:address><gtr:line1>Kiel University</gtr:line1><gtr:line2>Christian Albrechts Platz 4</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D"><gtr:id>E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D</gtr:id><gtr:name>Kiel University</gtr:name><gtr:address><gtr:line1>Kiel University</gtr:line1><gtr:line2>Christian Albrechts Platz 4</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/567827DE-34A2-4CFD-9DEE-7A123F17CDF3"><gtr:id>567827DE-34A2-4CFD-9DEE-7A123F17CDF3</gtr:id><gtr:firstName>Peer</gtr:firstName><gtr:surname>Wulff</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1100546"><gtr:id>4A887636-0EEA-4A00-B4D0-95DF13069100</gtr:id><gtr:title>Understanding the neuronal circuitry underlying Memory and Anxiety: the roles of GABA and CCK</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100546</gtr:grantReference><gtr:abstractText>Our brain processes information in a network of nerve cells. The communication between these nerve cells (neurons) occurs via specialized structures called synapses. When an electrical signal (action potential) travels along the neuron and reaches the synapse then a messenger substance is released from the synapse. This messenger substance is received by a receptor protein in the membrane of the adjacent nerve cell. In general nerve cells can be grouped into ?Yes-neurons?, which activate other neurons via their messenger substance and communicate information between different brain regions, and ?No-neurons?, which inactivate the ?Yes-cells? and thus regulate the flow of information. Dysfunction of subclasses of ?No-neurons? leads to pathological information-processing in psychiatric disorders. Recent studies have indicated that one particular sub-type of the ?No-neurons?, the so called CCK+ interneurons might be very important for controlling the flow of information related to the formation of memories and the regulation of mood and anxiety. We want to directly test the function of these particular ?No-neurons? in memory formation and fear/anxiety. To this end we are developing new methods that allow us to functionally remove specific nerve cells and messenger substances in model systems to test their behavioural relevance - similar to an electrician who goes through the components of a circuit board to identify a problem. Understanding how ?Yes neurons? and ?No-neurons? interact to generate memories and emotions will help to understand what is going wrong in memory and anxiety disorders and may lead to the development of new therapeutic strategies to treat such diseases.</gtr:abstractText><gtr:technicalSummary>Memory deficits as well as anxiety/mood disorders have a very high prevalence, cause substantial personal distress and represent a significant economic burden for society. Understanding the neuronal circuits underlying these pathologies is a prerequisite for new therapeutic strategies. However, progress in the field of circuit analysis has been slow due to the lack of methods with sufficient resolution. Using newly developed molecular tools we want to directly test the involvement of cholecystokinin (CCK)-expressing GABAergic interneurons in learning and memory and mood regulation. In the hippocampus, a structure critical for learning, recent studies indicate that CCK+ interneurons play a key role in orchestrating the encoding of spatial information by individual principal cells. Apart from GABA CCK+ interneurons also release the neuropeptide CCK, which strongly enhances memory performance after intra-hippocampal application, whereas CCK antagonists or knockout of CCK (or its receptor) impair memory performance. In addition, CCK-interneurons in the hippocampus and basolateral amygdala have been implicated in the regulation of emotion: They form a hub for inputs from neurotransmitters such as serotonin and neuromodulatory lipids such as endocannabinoids that control mood. Furthermore, CCK+ interneurons act through GABAA receptor types, which form the target of the most commonly used anxiolytics. Whereas injections of CCK, evoke fear and anxiety, CCK antagonists are strongly anxiolytic and reduce panic attacks in patients. 
The molecular techniques for high resolution in vivo circuit dissection that we have developed and will develop for this proposal put us into a unique position to directly test the hypothesis that CCK-interneurons play key roles in memory and emotion. To analyse their role in memory we will 1, functionally remove them from the hippocampus by cell-type-selective block of synaptic output with tetanus toxin and 2, independently perturb their GABAergic and CCKergic out-put by cell-type-selective knock down to dissect the neurotransmitter functions. We will investigate CCK-interneurons in anxiety by 3, targeting these cells in the basolateral amygdala. These perturbations will be analysed at the cellular (in vitro electrophysiology), network (local field potential recordings) and behavioural (memory and anxiety tests) level.</gtr:technicalSummary><gtr:fund><gtr:end>2015-11-10</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>602058</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The CamKII promoter should drive expression of Flp-recombinase mainly in principal cells.</gtr:description><gtr:id>CD62D230-5F15-4A65-ABFB-63CC76DAF18A</gtr:id><gtr:impact>This virus should allow removal or activation of genes in principal cells.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>AAV that expresses Flp recombinase under the CamKII promoter</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The transgene to be expressed by an adeno-associated virus is inserted between two sets of heterologous antiparallel sets of loxP sites (FLEX cassette), which is then flaked by two parallel Frt sites. This should allow gene expression in a poulation of neurons, which expresses Cre recombinase but not Flp recombinase in an intersectional gene targeting approach.</gtr:description><gtr:id>E52E2D52-A078-4A3B-9BDD-ECBD8E3AD467</gtr:id><gtr:impact>This should allow gene expression in a poulation of neurons, which expresses Cre recombinase but not Flp recombinase in an intersectional gene targeting approach.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Conditional AAV, where gene expression is activated by Cre recombinase and deactivated by Flp expression</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>we have generated cre recombinase-dependent rAAVs for microRNA-based shRNA knock down as proposed in the application. First Experiments in vitro suggest very good knock down efficiency.</gtr:description><gtr:id>C29FDE42-90FA-4EA4-8238-A1780F415D15</gtr:id><gtr:impact>This tool wil permitt the cell-type- and region-specific manipulation of defined molecules. We will use this tool to dissect the role of different but co-released transmitters in the brain.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>cell-specific rAAV mediated knock down</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>In analogy of the FLEX cassette which permits 100% tight Cre dependent transgene expression from e.g. AAV vectors, we have generated a FRT site-based cassette which works in vitro and vivo.</gtr:description><gtr:id>656CB0B0-A00B-4BCB-A51D-6201942D536B</gtr:id><gtr:impact>Combination of Cre and Flp based cassettes will permit leak-free intersectional targeting of transgene expression.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Flex cassette adapted to FRT sites</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C3A0C7E-25B3-42B4-927B-A25B9F085723"><gtr:id>3C3A0C7E-25B3-42B4-927B-A25B9F085723</gtr:id><gtr:title>Neural Tracing Methods</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e39ad0918732f409ce3b1988893923c0"><gtr:id>e39ad0918732f409ce3b1988893923c0</gtr:id><gtr:otherNames>Murray A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:isbn>978-1-4939-1962-8</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61DB6739-563C-4978-AAFF-2A87D531FA67"><gtr:id>61DB6739-563C-4978-AAFF-2A87D531FA67</gtr:id><gtr:title>The hippocampus in aging and disease: From plasticity to vulnerability.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/627d61226a771d8c64f38749e7f413fb"><gtr:id>627d61226a771d8c64f38749e7f413fb</gtr:id><gtr:otherNames>Bartsch T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E76B6E9-4E4B-4A0D-81F4-1DA3FD28BF38"><gtr:id>8E76B6E9-4E4B-4A0D-81F4-1DA3FD28BF38</gtr:id><gtr:title>GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/838b7b52121a0eeeec8709ae049f60cb"><gtr:id>838b7b52121a0eeeec8709ae049f60cb</gtr:id><gtr:otherNames>Zecharia AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49F3F087-6560-4097-BB85-F34F3DF9CC36"><gtr:id>49F3F087-6560-4097-BB85-F34F3DF9CC36</gtr:id><gtr:title>Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ac60c126dd05fe5ce69dfda4816f4de9"><gtr:id>ac60c126dd05fe5ce69dfda4816f4de9</gtr:id><gtr:otherNames>Murray AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100546</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>